Latest Market News

Oct 12
Cruise stocks soar to pace the S&P 500, as Norwegian is upgraded to buy

Shares of cruise operators were the top-3 gainers in the S&P 500 SPX, +0.03% in afternoon trading Wednesday, with Norwegian Cruise Line Holdings Ltd. NCLH, +12.13% getting bullish backing from UBS on the back of upbeat bookings data. Norwegian’s stock shot up 11.0%, Royal Caribbean Group shares RCL, +11.78% leapt 10.8% and Carnival Corp.’s stock […]

Oct 12
EIA expects a sharp rise in U.S. winter heating bills

The Energy Information Administration on Wednesday forecast that U.S. households that primarily use natural gas to heat their homes will likely spend an average of $931 this winter, which runs from October to March, up 28% from the amount they spent last winter. Natural-gas futures trade around 76% higher year to date, FactSet data show. […]

Oct 12
Charlotte’s Web shares jump on sponsorship pact with Major League Baseball

Charlotte’s Web Holdings Inc. CWBHF, +29.12% CWEB, +26.09% shares are rallying by nearly 23% after the company said it inked an exclusive, multi-year partnership with Major League Baseball to become the first official CBD in the sport. The deal “opens increased CBD visibility to their professional athletes, millions of fans and communities,” after a “rigorous […]

Oct 12
Private equity firm Veritas amasses $10.7 bln for flagship fund

Veritas Capital said Wednesday it drew in $10.65 billion in commitments for Veritas Capital Fund VIII, its latest flagship fund. The pool was “significantly oversubscribed” with demand exceeding its hard cap and initial target of $8.5 billion, the firm said. The flagship fund comes three years after Veritas Capital Fund VII closed with $6.5 billion […]

Oct 12
Merck, Moderna to develop personalized cancer vaccine

Merck & Co. Inc. MRK, -0.42% and Moderna Inc. MRNA, +8.76% said Wednesday that they plan to jointly develop and commercialize a personalized cancer vaccine. The investigational vaccine is currently being tested in a Phase 2 clinical trial as a treatment for patients with high-risk melanoma in combination with Merck’s Keytrduda, an anti-PD-1 therapy that […]

Oct 12
KnowBe4 shares rally on WSJ report of take-private deal with Vista Equity

Shares of KnowBe4 Inc. KNBE, +12.76% jumped 11% in premarket trades Wednesday after The Wall Street Journal reported that Vista Equity Partners plans to take the cyber security company private for about $4.5 billion. The offer price is nearly $25 a share, a premium over the stock’s close of $21.59 on Tuesday. Citing people familiar […]